Search Login Register

bevacizumab Summary

Description: anti-VEGF monoclonal antibody consisting of humanized murine antibody with antigen-binding, complementary-determining regions from murine VEGF; in clinical trials 12/02

Also Known As: Avastin

Networked: 7073 relevant articles (1337 outcomes, 1992 trials/studies) for this Drug

Key Diseases for which bevacizumab is Relevant

  1. Colorectal Neoplasms (Colorectal Cancer) : 269 outcomes 361 studies in 1066 results
  2. Neoplasms (Cancer) : 160 outcomes 313 studies in 1439 results
  3. Breast Neoplasms (Breast Cancer) : 111 outcomes 181 studies in 499 results
  4. Macular Edema : 105 outcomes 80 studies in 455 results
  5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) : 80 outcomes 146 studies in 364 results
Show All >>

Drugs Related to bevacizumab

  1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
  2. bevacizumab
  3. irinotecan (Camptosar)
  4. Paclitaxel (Taxol)
  5. oxaliplatin (Eloxatin)
  6. Fluorouracil (Carac)
  7. cetuximab (Erbitux)
  8. ranibizumab (Lucentis)
  9. capecitabine (Xeloda)
  10. Carboplatin (JM8)
Show All >>

Therapies Related to bevacizumab

  1. Drug Therapy (Chemotherapy)
  2. Intravitreal Injections
  3. Injections
  4. Light Coagulation
  5. Heterologous Transplantation (Xenotransplantation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.